Mankind Pharma Ltd (NSE:MANKIND) — Market Cap & Net Worth
Market Cap & Net Worth: Mankind Pharma Ltd (MANKIND)
Mankind Pharma Ltd (NSE:MANKIND) has a market capitalization of $10.19 Billion (Rs941.95 Billion) as of September 16, 2026. Listed on the NSE stock exchange, this India-based company holds position #2197 globally and #93 in its home market, demonstrating a -2.04% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Mankind Pharma Ltd's stock price Rs2280.50 by its total outstanding shares 413045090 (413.05 Million). Also see total assets of Mankind Pharma Ltd for a full breakdown of the balance sheet.
Mankind Pharma Ltd Market Cap History: 2023 to 2026
Mankind Pharma Ltd's market capitalization history from 2023 to 2026. Data shows growth from $8.86 Billion to $10.19 Billion (15.10% CAGR). Also see cash flow conversion of Mankind Pharma Ltd for how efficiently the company converts equity into cash flow.
Index Memberships
Mankind Pharma Ltd is a constituent of 7 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NIFTY PHARMA
CNXPHARMA
|
$100.49 Billion | 10.14% | #6 of 20 |
|
NIFTY MIDCAP 100
NIFMDCP100
|
$516.25 Billion | 1.97% | #16 of 100 |
|
NIFTY 200
NIFTY200
|
$2.46 Trillion | 0.41% | #83 of 200 |
|
NIFTY 500
NIFTY500
|
$3.03 Trillion | 0.34% | #87 of 500 |
|
NIFTY MIDCAP 150
NIFTYMIDCAP150
|
$690.63 Billion | 1.48% | #18 of 150 |
|
NIFTY MIDSMALLCAP 400
NIFTYMIDSML400
|
$1.13 Trillion | 0.90% | #25 of 400 |
|
NIFTY TOTAL MARKET
NIFTYTOTALMKT
|
$3.13 Trillion | 0.33% | #87 of 750 |
Weight: Mankind Pharma Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Mankind Pharma Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Mankind Pharma Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check MANKIND share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.07x
Mankind Pharma Ltd's market cap is 0.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.53x
Mankind Pharma Ltd's market cap is 0.53 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2023 | $8.86 Billion | $87.49 Billion | $12.82 Billion | 0.10x | 0.69x |
| 2024 | $12.87 Billion | $102.59 Billion | $19.13 Billion | 0.13x | 0.67x |
| 2025 | $9.81 Billion | $122.07 Billion | $19.91 Billion | 0.08x | 0.49x |
| 2026 | $10.19 Billion | $142.78 Billion | $19.13 Billion | 0.07x | 0.53x |
Competitor Companies of MANKIND by Market Capitalization
Companies near Mankind Pharma Ltd in the global market cap rankings as of September 16, 2026. Review Mankind Pharma Ltd tangible equity quality to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Mankind Pharma Ltd by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #631 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #636 globally with a market cap of $43.34 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #672 globally with a market cap of $40.69 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #631 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.00 |
| #636 | GALDERMA GROUP AG | NYSE:GALDY | $43.34 Billion | $37.18 |
| #672 | Haleon plc | NYSE:HLN | $40.69 Billion | $9.24 |
Mankind Pharma Ltd Historical Marketcap From 2023 to 2026
Between 2023 and today, Mankind Pharma Ltd's market cap moved from $8.86 Billion to $ 10.19 Billion, with a yearly change of 15.10%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rs10.19 Billion | +3.82% |
| 2025 | Rs9.81 Billion | -23.74% |
| 2024 | Rs12.87 Billion | +45.29% |
| 2023 | Rs8.86 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Mankind Pharma Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $10.19 Billion USD |
| MoneyControl | $10.19 Billion USD |
| MarketWatch | $10.19 Billion USD |
| marketcap.company | $10.19 Billion USD |
| Reuters | $10.19 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Mankind Pharma Ltd
Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, gynaecology, urology, anti-diabetic, dermatology, pain/analgesics, neuro/CNS, vitamins/minerals/nutrients, resp… Read more